一个病例报告的抗AMPAR脑炎与非自愿的四肢震动和失语症
Shuang Li1,2, Tiantian Huo2, Minxia Geng2,3
1Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
Medicine
|April 7, 2025
概括
抗α-amino-3-hydroxy-5-methyl-4-isoxazolylpropionic acid receptor (AMPAR) 脑炎是一种罕见的自身免疫性疾病,可以出现各种症状,如四肢. 在一项案例研究中,早期诊断和免疫疗法治疗导致完全康复.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
背景情况:
- 抗α-amino-3-hydroxy-5-methyl-4-isoxazolylpropionic酸受体 (AMPAR) 脑炎是一种罕见的自身免疫性疾病.
- 它的特征是抗体攻击神经元表面受体,导致各种临床表现,包括记忆丧失,混乱,行为变化和发作.
研究的目的:
- 报告一个反AMPAR脑炎病例,在一个青春期的女性中呈现出失言症和非自愿的四肢震动.
- 突出了在自身免疫性脑炎中非典型的初始症状所带来的诊断挑战.
主要方法:
- 临床病例的介绍.
- 基于临床症状和血清抗AMPAR抗体检测的诊断.
- 用静脉注射甲基prednisolone和免疫球蛋白治疗的治疗.
主要成果:
- 患者经历了失言症和非自愿的四肢动作为最初的症状.
- 迅速的免疫疗法导致症状消失,患者恢复了流利的言语和肢体运动的停止.
- 患者对联合治疗方案表现出积极反应.
结论:
- 自身免疫性脑炎的诊断因异质的临床表现而复杂化.
- 失言症和非自愿的四肢运动可能是抗AMPAR脑炎的初始症状.
- 对自身免疫性脑炎的各种症状进行进一步的研究是有必要的,以便更早地检测和干预.
更多相关视频
相关概念视频
Myasthenia Gravis: Diagnostic Tests
561
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
561
Arteries of the Lower Limbs
171
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
171
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Parkinson's Disease: Overview
342
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
342


